Original News Release
Jamieson Wellness Inc. Reports Third Quarter 2025 Results
Marketing and product innovations continue to drive high consumer engagement and double-digit revenue growth across the Company’s portfolio of leading consumer brands
Company Website: https://www.jamiesonwellness.com/English/home/default.aspx
TORONTO -- (Business Wire)
Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported its third quarter results for the period ended September 30, 2025. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other financial measures. See “Non-IFRS and Other Financial Measures” below.
Management Commentary
“In Q3, Jamieson delivered another strong quarter with 16.5% branded growth and momentum across every major region,” said Mike Pilato, President and CEO. “In Canada, our marketing campaign featuring our product quality and Canadian-made message continues to resonate, driving growth and reinforcing trust in a market where we're the category leader.
“In China, we grew our share position across all major digital platforms. Our evolving marketing strategy is delivering solid results, amplified by a diverse network of respected wellness influencers. Jamieson was recently named VMS Store of the Year on Douyin, a social and e-commerce platform with over 700 million daily active users. It's a powerful endorsement of our brand strength and execution in one of the world's most dynamic consumer markets.
“Youtheory continues to scale in the U.S., with strong growth in both digital and traditional channels. Product innovations, led by our new ashwagandha gummy, drove deeper consumer engagement with the brand. And internationally, we're seeing double digit growth in key markets led by the Middle East, with strong gains in Saudia Arabia where Jamieson is now a leading foreign brand.
“Even against a volatile macro backdrop, our category continues to prove its resilience. VMS is increasingly central to how consumers care for themselves and their families, and with our diverse and growing branded platform, we're uniquely positioned to meet them - across geographies, across channels, and across life stages. I’m grateful to the entire Jamieson team for their expert execution, delivering exceptional results today and building long-term value for our shareholders.”
Third Quarter Highlights
Successful innovation and the Company’s recent quality-focused advertising campaign drove continued strong consumer consumption in Canada
Digital e-commerce growth outpaced the market in China due to evolving influencer marketing strategy, impacting all channels and resulting in over 60% revenue growth
youtheory POS increased as the Company’s new digital e-commerce strategy continues to perform and traditional retail continues to grow
International growth continued in key markets including Saudi Arabia, the Caribbean and Europe driven by new distribution and high consumer engagement
Summary of Consolidated Results
All comparisons are with the third quarter of 2024
Consolidated revenue increased 13.2% to $199.3 million, driven by 16.5% growth in Jamieson Brands, partially offset by an expected decline in Strategic Partners
Gross profit increased by $16.0 million to $83.6 million, driven by higher branded revenue and margins
Gross profit margin3 increased by 350 basis points due to a higher proportion of growth in Jamieson Brands sales
EBITDA1 increased by $5.2 million to $33.1 million, mainly driven by higher revenues and gross profit; Adjusted EBITDA1 increased by $4.1 million or 12.0% to $38.0 million, reflecting the impact of higher sales volumes, partially offset by timing of investments in SG&A
Net earnings was $15.5 million; Adjusted net earnings1 was $17.7 million, or $1.8 million higher, reflecting higher normalized earnings from operations
Diluted earnings per share was $0.35; Adjusted diluted earnings per share2 was $0.41
Summary of Segment Results
All comparisons are with the third quarter of 2024
Jamieson Brands
Revenue increased 16.5% or $25.5 million
Canada revenue increased by 4.0%, largely reflecting consumer consumption driven by the Company’s latest marketing campaign and innovations
China revenue increased 63.0% primarily driven by successful digital performance marketing campaigns
youtheory revenue increased by 16.8%, driven by continued strong consumption in e-commerce and growth in the Company’s traditional channels
International revenue increased by 19.3%, driven by growth in core markets in the Middle East through innovation and distribution gains
Gross profit increased by $16.0 million to $81.3 million, mainly driven by revenue growth and higher margins
Gross profit margin3 increased by 290 basis points, mainly driven by higher branded volumes in China, the Company’s highest margin business
Adjusted EBITDA1 increased by $4.1 million to $36.5 million, driven by higher gross profit partially offset by timing of marketing spend; Adjusted EBITDA margin2 was 20.2%, a decrease of 70 basis points driven by investment in marketing noted above
Strategic Partners
Revenue decreased an expected 11.2% or $2.4 million, impacted by a reduction in business and the timing of onboarding new customer contracts amidst trade and tariff uncertainties
Gross profit was $2.4 million, consistent with Q3 2024; gross profit margin3 increased by 170 basis points driven mainly by customer and product mix
Adjusted EBITDA1 was $1.5 million; Adjusted EBITDA margin2 was 8.0%, an increase of 60 basis points, mainly due to customer and product mix
Balance Sheet and Cash Flow from Operations
All comparisons are with the third quarter of 2024
As at September 30, 2025, the Company had approximately $128.8 million in cash and available revolving and swingline facilities and net debt1 of $371.2 million
The Company generated $7.7 million in cash from operations compared to $24.2 million generated in Q3 2024
Cash from operating activities before working capital considerations of $22.8 million was $4.3 million higher than Q3 2024
Cash invested in working capital increased by $20.8 million mainly due to increased inventories to support the high seasonality fourth quarter deliverables including growth of the business and securing supply amidst tariff uncertainties and port congestion
During the nine-month period ended September 30, 2025, the Company purchased for cancellation 636,284 common shares under its NCIB program for an aggregate consideration of $19.7 million
1 This is a non-IFRS financial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS financial measure.
2 This is a non-IFRS ratio. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS ratio.
3 This is a supplementary financial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each supplementary financial measure.
Narrowing Fiscal 2025 Outlook
The Company’s 2025 investments in digital marketing and innovation continue to provide returns, and consumer consumption remains strong across each of our primary markets. As a result, the Company has narrowed its full year consolidated guidance for fiscal 2025, while maintaining the midpoint of its previous growth expectation for both revenue and Adjusted EBITDA.
The Company now expects the following consolidated results:
Revenue to range from $810.0 - $830.0 million or 10.4% - 13.1% growth (previously 9.0% - 14.5% growth)
Adjusted EBITDA to range from $158.0 - $162.0 million or 12.0% - 15.0% growth (previously 11.0% - 15.5% growth)
Adjusted Diluted EPS to range from $1.82 - $1.88 or 13.0% - 17.0% growth (previously 11.0% - 18.0% growth)
The Company is adjusting its segment outlook for the 2025 fiscal year to reflect higher Jamieson Brands revenue in China and youtheory, and lower Strategic Partners revenue to account for currency conversation and tariff uncertainty related delays.
The Company now expects the following segment results:
Revenue in the Jamieson Brands segment to range from $710.0 - $725.0 million, or 12.9% - 15.3% growth (previously 10.5% - 15.3% growth)
Canada revenue growth of 5.0% - 7.0% (previously 5.0% - 8.0% growth)
youtheory revenue growth of 8.0% - 12.0% (previously 5.0% - 15.0% growth)
China revenue growth of 45.0% - 50.0% (previously 30.0% - 40.0% growth)
International revenue growth of 20.0% - 25.0% (previously 20% - 30% growth)
Strategic Partners revenue to decline approximately 5.0% (previously up to 10.0%)
The Company’s 2025 guidance reflects the current prevailing trade environment between the United States, Canada and other countries. To date, tariffs have not had a material impact on the Company’s overall financial performance, as a majority of these costs have been mitigated through our flexible supply chain and operating efficiencies. The Company recognizes that the trade environment is constantly changing, and actual results may be impacted by future changes in global trade policies. For additional details on the Company’s fiscal 2025 outlook, including guidance for the fourth quarter of 2025, refer to the “Outlook” section in the management’s discussion and analysis of financial condition and results of operations (“MD&A”) for the three months ended September 30, 2025.
Declaration of Third Quarter Dividend
The board of directors of the Company declared a cash dividend for the third quarter of 2025 of $0.23 per common share, or approximately $9.6 million in total.
Payable: December 15, 2025
Record date: December 1, 2025
Designated an “eligible dividend” under the Income Tax Act (Canada)
Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s unaudited condensed consolidated interim financial statements and accompanying notes as at and for the three and nine months ended September 30, 2025 and related MD&A are available under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Investor Relations section of the Company’s website at https://investors.jamiesonwellness.com.
Conference Call
Management will host a conference call to discuss the Company’s third quarter 2025 results at 5:00 p.m. ET today, November 6, 2025. To access:
By phone: 1-800-717-1738 from Canada and the U.S. or 1-646-307-1865 from international locations
Online: https://investors.jamiesonwellness.com or https://viavid.webcasts.com/starthere.jsp?ei=1738878&tp_key=18b6589547
About Jamieson Wellness
Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada's #1 vitamins, minerals and supplements (“VMS”) brand. The Company’s youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit jamiesonwellness.com.
Jamieson Wellness’ head office is located at 1 Adelaide Street East Suite 2200, Toronto, Ontario, Canada.
Forward-Looking Information
This press release may contain forward-looking information within the meaning of applicable securities legislation. Such information includes, but is not limited to, statements related to the Company’s anticipated results and its outlook for its 2025 revenue, Adjusted EBITDA and Adjusted diluted earnings per share. Words such as “expect”, “anticipate”, “intend”, “may”, “will”, “estimate” and variations of such words and similar expressions are intended to identify such forward-looking information. This information reflects the Company’s current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond the Company’s control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, the factors discussed under “Risk Factors” in the Company’s Annual Information Form dated March 31, 2025 and under the “Risk Factors” section in the MD&A filed today, November 6, 2025. This information is based on the Company’s reasonable assumptions and beliefs in light of the information currently available to it and the statements are made as of the date of this press release. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law or regulatory authority.
The Company cautions that the list of risk factors and uncertainties is not exhaustive and other factors could also adversely affect the Company’s results. Readers are urged to consider the risks, uncertainties and assumptions associated with these statements carefully in evaluating the forward-looking information and are cautioned not to place undue reliance on such information. See “Forward-looking Information” and “Risk Factors” within the MD&A for a discussion of the uncertainties, risks and assumptions associated with these statements.
Jamieson Wellness Inc.
Selected Consolidated Financial Information
In thousands of Canadian dollars, except share and per share amounts
Three months ended Nine months ended
September 30 September 30
2025
2024
2025
2024
Revenue
199,325
176,155
544,397
488,999
Cost of sales
115,710
108,584
324,748
313,615
Gross profit
83,615
67,571
219,649
175,384
Gross profit margin
41.9%
38.4%
40.3%
35.9%
Selling, general and administrative expenses
52,341
41,982
157,274
125,407
Share-based compensation
2,118
1,788
6,283
5,281
Earnings from operations
29,156
23,801
56,092
44,696
Operating margin
14.6%
13.5%
10.3%
9.1%
Foreign exchange loss/(gain)
935
578
(310)
(373)
Interest expense and other financing costs
6,329
5,068
16,008
14,588
Accretion on preferred shares
-
2,169
3,427
6,509
Earnings before income taxes
21,892
15,986
36,967
23,972
Provision for income taxes
6,379
5,568
10,140
8,960
Net earnings
15,513
10,418
26,827
15,012
Net earnings attributable to:
Shareholders
14,979
10,564
25,604
15,104
Non-controlling interests
534
(146)
1,223
(92)
15,513
10,418
26,827
15,012
Adjusted net earnings
17,679
15,834
40,894
34,403
EBITDA
33,095
27,934
71,010
59,441
Adjusted EBITDA
37,969
33,914
92,135
81,566
Adjusted EBITDA margin
19.0%
19.3%
16.9%
16.7%
Weighted average number of shares
Basic
41,819,276
41,566,805
41,836,515
41,501,326
Diluted
43,091,108
42,943,970
43,044,430
42,747,176
Earnings per share attributable to common shareholders:
Basic, earnings per share
0.36
0.25
0.61
0.36
Diluted, earnings per share
0.35
0.24
0.59
0.35
Adjusted diluted, earnings per share
0.41
0.37
0.95
0.80
Jamieson Wellness Inc.
Consolidated Statements of Financial Position
In thousands of Canadian dollars
September 30,
2025
December 31,
2024
Assets
Current assets
Cash
48,816
44,787
Accounts receivable
151,593
228,031
Inventories
236,645
154,658
Derivatives
274
2,661
Prepaid expenses and other current assets
9,331
6,803
Income taxes recoverable
1,479
-
448,138
436,940
Non-current assets
Property, plant and equipment
112,861
103,591
Goodwill
282,248
287,503
Intangible assets
366,680
377,214
Deferred income tax
4,126
3,545
Total assets
1,214,053
1,208,793
Liabilities
Current liabilities
Accounts payable and accrued liabilities
154,333
137,653
Income taxes payable
1,532
4,373
Derivatives
2,146
2,982
Current portion of other long-term liabilities
17,687
27,673
175,698
172,681
Long-term liabilities
Long-term debt
420,000
308,285
Post-retirement benefits
1,297
1,209
Deferred income tax
63,133
64,467
Redeemable preferred shares
-
98,138
Other long-term liabilities
24,079
15,633
Total liabilities
684,207
660,413
Equity
Share capital
337,833
326,219
Warrants
14,705
14,705
Contributed surplus
25,051
23,835
Retained earnings
82,669
99,109
Accumulated other comprehensive income
25,840
41,313
Total shareholders' equity
486,098
505,181
Non-controlling interests
43,748
43,199
Total equity
529,846
548,380
Total liabilities and equity
1,214,053
1,208,793
Non-IFRS and Other Financial Measures
This press release makes reference to certain financial measures, including non-IFRS financial measures that are historical, non-IFRS measures that are forward-looking, non-GAAP ratios and supplementary financial measures. Management uses these financial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of ongoing operations and in analyzing the Company’s business performance and trends. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company’s results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the Company’s financial information reported under IFRS. The Company uses the following non-IFRS financial measures: “EBITDA”, “Adjusted EBITDA” and “Adjusted net earnings”, the most directly comparable financial measure for each that is disclosed in its financial statements being net earnings, “normalized gross profit”, “normalized SG&A”, “normalized earnings from operations”, “cash from operating activities before working capital considerations” and “net debt”, the most directly comparable financial measures for each that is disclosed in its financial statements being gross profit, SG&A, earnings from operations, cash flows from operating activities, and long-term debt, respectively, the following non-IFRS ratios: “Adjusted EBITDA margin”, “Adjusted diluted earnings per share”, “normalized gross profit margin”, “normalized operating margin”, and the following supplementary financial measures: “gross profit margin” and “operating margin” to provide supplemental measures of the Company’s operating performance and thus highlight trends in the Company’s core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also uses non-IFRS and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. For an explanation of the composition of each such measure and the usefulness and additional uses of each by management, see the “How we Assess the Performance of our Business” section of the MD&A, which is incorporated by reference. See below for a quantitative reconciliation of each non-IFRS financial measure to its most directly comparable financial measure disclosed in the Company’s financial statements to which the measure relates.
The following tables provide a quantitative reconciliation of net earnings to EBITDA, Adjusted EBITDA, and Adjusted net earnings, as well as gross profit to normalized gross profit, SG&A to normalized SG&A, earnings from operations to normalized earnings from operations and net debt, each of which are non-IFRS financial measures (see the “Non-IFRS and Other Financial Measures” of this press release for further information on each non-IFRS financial measure) for the three and nine months ended September 30, 2025.
Jamieson Wellness Inc.
Segment Information
In thousands of Canadian dollars, except as otherwise noted
Jamieson Brands
Three months ended
September 30
2025
2024
$ Change
% Change
Revenue
180,523
154,988
25,535
16.5%
Gross profit
81,253
65,257
15,996
24.5%
Gross profit margin
45.0%
42.1%
-
2.9%
Share-based compensation (3)
2,118
1,788
330
18.5%
Selling, general and administrative expenses
50,815
40,516
10,299
25.4%
Acquisition and divestiture related costs (2)
-
(541)
541
100.0%
IT system implementation (4)
(1,363)
(2,992)
1,629
54.4%
Legal and other (6)
(458)
(81)
(377)
(465.4%)
Normalized selling, general and administrative expenses
48,994
36,902
12,092
32.8%
Earnings from operations
28,320
22,953
5,367
23.4%
Acquisition and divestiture related costs (2)
-
541
(541)
(100.0%)
IT system implementation (4)
1,363
2,992
(1,629)
(54.4%)
Legal and other (6)
458
81
377
465.4%
Normalized earnings from operations
30,141
26,567
3,574
13.5%
Operating margin
15.7%
14.8%
-
0.9%
Normalized operating margin
16.7%
17.1%
-
(0.4%)
Adjusted EBITDA
36,469
32,340
4,129
12.8%
Adjusted EBITDA margin
20.2%
20.9%
-
(0.7%)
Strategic Partners
Three months ended
September 30
2025
2024
$ Change
% Change
Revenue
18,802
21,167
(2,365)
(11.2%)
Gross profit
2,362
2,314
48
2.1%
Gross profit margin
12.6%
10.9%
-
1.7%
Selling, general and administrative expenses
1,526
1,466
60
4.1%
Earnings from operations
836
848
(12)
(1.4%)
Operating margin
4.4%
4.0%
-
0.4%
Adjusted EBITDA
1,500
1,574
(74)
(4.7%)
Adjusted EBITDA margin
8.0%
7.4%
-
0.6%
Jamieson Brands
Nine months ended
September 30
2025
2024
$ Change
% Change
Revenue
489,221
426,123
63,098
14.8%
Gross profit
213,294
167,671
45,623
27.2%
Labour relations costs (1)
-
4,713
(4,713)
(100.0%)
IT system implementation (4)
1,023
-
1,023
100.0%
Acquisition and divestiture related costs (2)
-
165
(165)
(100.0%)
Normalized gross profit
214,317
172,549
41,768
24.2%
Gross profit margin
43.6%
39.3%
-
4.3%
Normalized gross profit margin
43.8%
40.5%
-
3.3%
Share-based compensation (3)
6,283
5,281
1,002
19.0%
Selling, general and administrative expenses
152,622
120,839
31,783
26.3%
Acquisition and divestiture related costs (2)
-
(865)
865
100.0%
IT system implementation (4)
(9,445)
(9,421)
(24)
(0.3%)
Labour relations costs (1)
-
(1,675)
1,675
100.0%
Donations (5)
(3,118)
-
(3,118)
(100.0%)
Legal and other (6)
(1,340)
(378)
(962)
(254.5%)
Normalized selling, general and administrative expenses
138,719
108,500
30,219
27.9%
Earnings from operations
54,389
41,551
12,838
30.9%
Acquisition and divestiture related costs (2)
-
1,030
(1,030)
(100.0%)
IT system implementation (4)
10,468
9,421
1,047
11.1%
Labour relations costs (1)
-
6,388
(6,388)
(100.0%)
Donations (5)
3,118
-
3,118
100.0%
Legal and other (6)
1,340
378
962
254.5%
Normalized earnings from operations
69,315
58,768
10,547
17.9%
Operating margin
11.1%
9.8%
-
1.3%
Normalized operating margin
14.2%
13.8%
-
0.4%
Adjusted EBITDA
88,197
76,155
12,042
15.8%
Adjusted EBITDA margin
18.0%
17.9%
-
0.1%
Strategic Partners
Nine months ended
September 30
2025
2024
$ Change
% Change
Revenue
55,176
62,876
(7,700)
(12.2%)
Gross profit
6,355
7,713
(1,358)
(17.6%)
IT system implementation (4)
226
-
226
100.0%
Normalized gross profit
6,581
7,713
(1,132)
(14.7%)
Gross profit margin
11.5%
12.3%
-
(0.8%)
Normalized gross profit margin
11.9%
12.3%
-
(0.4%)
Selling, general and administrative expenses
4,652
4,568
84
1.8%
Earnings from operations
1,703
3,145
(1,442)
(45.9%)
IT system implementation (4)
226
-
226
100.0%
Normalized earnings from operations
1,929
3,145
(1,216)
(38.7%)
Operating margin
3.1%
5.0%
-
(1.9%)
Normalized operating margin
3.5%
5.0%
-
(1.5%)
Adjusted EBITDA
3,938
5,411
(1,473)
(27.2%)
Adjusted EBITDA margin
7.1%
8.6%
-
(1.5%)
Reconciliation of Non-IFRS Financial Measures
In thousands of Canadian dollars
Three months ended Nine months ended
September 30 September 30
2025
2024
2025
2024
Net earnings:
15,513
10,418
26,827
15,012
Add:
Recovery of income taxes
6,379
5,568
10,140
8,960
Interest expense and other financing costs
6,329
5,068
16,008
14,588
Accretion on preferred shares
-
2,169
3,427
6,509
Depreciation of property, plant, and equipment
3,419
3,201
10,148
9,953
Amortization of intangible assets
1,455
1,510
4,460
4,419
Earnings before interest, taxes, depreciation, and amortization (EBITDA)
33,095
27,934
71,010
59,441
Share-based compensation (3)
2,118
1,788
6,283
5,281
Foreign exchange loss/(gain)
935
578
(310)
(373)
Labour relations costs (1)
-
-
-
6,388
IT system implementation (4)
1,363
2,992
10,694
9,421
Acquisition and divestiture related costs (2)
-
541
-
1,030
Donations (5)
-
-
3,118
-
Legal and other (6)
458
81
1,340
378
Adjusted EBITDA
37,969
33,914
92,135
81,566
Recovery of income taxes
(6,379)
(5,568)
(10,140)
(8,960)
Interest expense and other financing costs
(6,329)
(5,068)
(16,008)
(14,588)
Depreciation of property, plant, and equipment
(3,419)
(3,201)
(10,148)
(9,953)
Amortization of intangible assets
(1,455)
(1,510)
(4,460)
(4,419)
Share-based compensation (3)
(1,996)
(1,666)
(5,917)
(4,915)
Tax deduction from vesting of certain share-based awards
-
-
(708)
-
Tax effect of normalization adjustments
(712)
(1,067)
(3,860)
(4,328)
Adjusted net earnings
17,679
15,834
40,894
34,403
Three months ended Nine months ended
September 30 September 30
2025
2024
2025
2024
Gross profit
83,615
67,571
219,649
175,384
Labour relations costs (1)
-
-
-
4,713
Acquisition and divestiture related costs (2)
-
-
-
165
IT system implementation (4)
-
-
1,249
-
Normalized gross profit
83,615
67,571
220,898
180,262
Normalized gross profit margin
41.9%
38.4%
40.6%
36.9%
Selling, general and administrative expenses
52,341
41,982
157,274
125,407
Acquisition and divestiture related costs (2)
-
(541)
-
(865)
IT system implementation (4)
(1,363)
(2,992)
(9,445)
(9,421)
Labour relations costs (1)
-
-
-
(1,675)
Donations (5)
-
-
(3,118)
-
Legal and other (6)
(458)
(81)
(1,340)
(378)
Normalized selling, general and administrative expenses
50,520
38,368
143,371
113,068
Earnings from operations
29,156
23,801
56,092
44,696
Acquisition and divestiture related costs (2)
-
541
-
1,030
IT system implementation (4)
1,363
2,992
10,694
9,421
Donations (5)
-
-
3,118
-
Labour relations costs (1)
-
-
-
6,388
Legal and other (6)
458
81
1,340
378
Normalized earnings from operations
30,977
27,415
71,244
61,913
Normalized operating margin
15.5%
15.6%
13.1%
12.7%
(1)
These expenses are mainly comprised of third-party legal, security fees, unavoidable facility expenditures, customer fines and penalties, along with freight charges to expedite shipments to customers as it relates to a labour disruption in Q1 2024.
(2)
Prior year expenses mainly pertain to legal, consulting and integration costs associated with the acquisition and integration of our former distributor partner in China on April 28, 2023.
(3)
The Company’s share-based compensation expense pertains to our long-term incentive plan (the “LTIP”) (refer to “Share-based compensation”), with stock options, performance-based share units (“PSUs”), time-based restricted share units (“RSUs”), and deferred share units (“DSUs”) expenses, along with associated payroll taxes.
(4)
Mainly pertains to development costs associated with our IT system implementation to augment our system infrastructure. Unlike other system improvement projects with costs capitalized, due to its cloud-based nature, these system implementation costs are expensed accordingly.
(5)
Include cash and in-kind donations to support communities adjacent to our Irvine, California facility impacted by the wildfires.
(6)
Includes other non-recurring expenses primarily related to non-operational legal costs.
Reconciliation of Net Debt
In thousands of Canadian dollars
($ in 000's)
As at September 30,
As at December 31,
2025
2024
Long-term debt
420,000
308,285
Cash
(48,816)
(44,787)
Net debt
371,184
263,498
View source version on businesswire.com: https://www.businesswire.com/news/home/20251106634726/en/
Contacts:
Investor and Media Contact Information:
Jamieson Wellness
Ruth Winker
416-960-0052
[email protected]
Source: Jamieson Wellness Inc.
View at source ↗